Fresh insights into how cystic fibrosis affects immune cells could pave the way for new treatments for the condition, Scots researchers believe.
Scientists have discovered that cells in patients with cystic fibrosis that normally defend against infection can also perpetuate damage to the lungs.
Drugs that target these cells could help to stem progression of the disease, they claim.
A team at the University of Edinburgh, with researchers in the US and Ireland, focused on immune cells known as neutrophils - part of the body's first line of defence against infections.
Once an infection has been cleared, neutrophils are usually programmed to die off quietly, so that they do not mistakenly cause damage to healthy tissues.
However, in patients with cystic fibrosis, neutrophils survive longer than they are supposed to and are a key contributor to the lung damage associated with the condition, experts said.
The team discovered that neutrophils from cystic fibrosis patients are more resistant to the usual mechanism of cell death - a process called apoptosis - with their ability to survive longer directly related to the underlying genetic mutation that causes cystic fibrosis.
Instead, the cells die by a different process, which causes them to disintegrate and expel their damaging contents into the surrounding area of the lung, experts said.
This process promotes inflammation and may therefore promote damage to healthy tissues in the lung.
Researchers said they were able to block this process by treatment with a drug that encourages neutrophils to die by apoptosis, paving the way for new therapies for the disease.
Dr Robert Gray, of the Medical Research Council Centre for Inflammation Research at Edinburgh University, said: "Therapies targeting inflammation are not readily available but are needed for the treatment of cystic fibrosis.
"This work, although at an early stage, will help in the development of new anti-inflammatory treatments for this debilitating condition."
Cystic fibrosis causes thick mucus to build up in patient's lungs and digestive tracts. It causes persistent coughs and breathing difficulties, as well as leaving patients vulnerable to recurrent infections. Around 11,000 people in the UK are living with the disease.
The research, published in the journal Thorax, was funded by the Medical Research Council and Wellcome.
ends
Why are you making commenting on The Herald only available to subscribers?
It should have been a safe space for informed debate, somewhere for readers to discuss issues around the biggest stories of the day, but all too often the below the line comments on most websites have become bogged down by off-topic discussions and abuse.
heraldscotland.com is tackling this problem by allowing only subscribers to comment.
We are doing this to improve the experience for our loyal readers and we believe it will reduce the ability of trolls and troublemakers, who occasionally find their way onto our site, to abuse our journalists and readers. We also hope it will help the comments section fulfil its promise as a part of Scotland's conversation with itself.
We are lucky at The Herald. We are read by an informed, educated readership who can add their knowledge and insights to our stories.
That is invaluable.
We are making the subscriber-only change to support our valued readers, who tell us they don't want the site cluttered up with irrelevant comments, untruths and abuse.
In the past, the journalist’s job was to collect and distribute information to the audience. Technology means that readers can shape a discussion. We look forward to hearing from you on heraldscotland.com
Comments & Moderation
Readers’ comments: You are personally liable for the content of any comments you upload to this website, so please act responsibly. We do not pre-moderate or monitor readers’ comments appearing on our websites, but we do post-moderate in response to complaints we receive or otherwise when a potential problem comes to our attention. You can make a complaint by using the ‘report this post’ link . We may then apply our discretion under the user terms to amend or delete comments.
Post moderation is undertaken full-time 9am-6pm on weekdays, and on a part-time basis outwith those hours.
Read the rules here